XI’AN, China, May 02, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions for the natural, health, and personal care sectors, announced today that it received a notification letter on April 29, 2025, from Nasdaq’s Listing Qualifications Staff (“Staff”). The letter stated that the Company doesn’t meet Nasdaq Listing Rule 5450(a)(1), the Minimum Bid Price Requirement. This is because the Company’s Class A ordinary shares closed below $1.00 per share for the previous 30 consecutive business days, which could lead to the Company’s securities being delisted from Nasdaq. Additionally, because the Company’s securities had a closing bid of $0.10 or less for the last ten consecutive trading days, it is subject to delisting under Listing Rule 5810(c)(3)(A)(iii), and is ineligible for a compliance period.
On May 1, 2025, the Company received another notification letter stating that the Staff decided to delist the Company’s securities, using their discretionary authority under Listing Rule 5101. The Staff’s decision was influenced by concerns about the public interest related to the Company’s best efforts offering in March 2025.
The Company has appealed and requested a hearing with a Nasdaq Listing Qualifications Panel to review the Staff’s decision. The delisting of the Company’s securities is suspended while the Panel makes its decision.
The Company will consider its options for regaining compliance with the Listing Rules. However, the Company cannot guarantee that it will be able to regain or maintain compliance, or that its appeal to the Panel will be successful.
About Bon Natural Life Limited
BON, a Cayman Islands company, operates in the natural, health, and personal care industries. For more information, please visit .
Forward-Looking Statements
This announcement contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. These statements can be identified by words like “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” and similar expressions. While the Company believes these forward-looking statements are reasonable, it cannot guarantee their accuracy and cautions investors that actual results may differ significantly. These statements are based on current beliefs, expectations, and assumptions about the future of the business, plans, strategies, projections, events, trends, the economy, regulatory activities, and other future conditions. Because they relate to the future, these statements are subject to uncertainties, risks, and changes that are difficult to predict and beyond the Company’s control. Therefore, reliance on these statements is not advised. These risks include, among others: the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds from the offering, BON’s limited operating history and historical losses; BON’s ability to raise additional funding; competition from third parties that are developing or have products for similar uses; BON’s ability to obtain, maintain and protect its intellectual property; and BON’s expectations regarding its growth, strategy, progress towards its goals. These forward-looking statements are based on current expectations and projections about future events and financial trends that may affect the Company’s financial condition, results of operations, business strategy, and financial needs. The Company is not obligated to update these statements to reflect new events or circumstances, except as required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.
Investor Relations Contact:
Cindy Liu | IR
Email: bonnatural@appchem.cn
“`